Project Grant 2500009

Award Date 4/15/25
Completion Date 3/31/26
Dollars Obligated $303K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Morgantown, WV, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $295,759 to Cortechs Labs, Inc. (doing business as Cortechs AI) to develop and validate software for detecting and quantifying Amyloid-Related Imaging Abnormalities (ARIA) in the brains of Alzheimer's disease patients undergoing treatment with amyloid-clearing drugs. The key objectives are to create clinically-deployable software tools that can automatically detect and measure ARIA lesions,...
This $256,000 National Science Foundation Project Grant under the Engineering (47.041) program will support the development of an artificial intelligence-based system for analyzing multiparametric magnetic resonance imaging (MRI) scans to detect prostate lesions. The awardee, Taurus Diagnostics, Inc., will create a novel prostate cancer diagnostic platform leveraging artificial intelligence image analysis for high sensitivity and specificity. Key objectives include developing methods to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Macula Vision Systems Inc., a for-profit organization, supports the development of a novel microscopy platform to automate the interpretation of microbiology lab tests performed in hospitals. The project aims to address the shortage of trained lab technicians by engineering a specialized light source, customized camera, and AI-enabled algorithms to analyze...
This $276,000 National Science Foundation award through the Technology, Innovation, and Partnerships program will support the development of a cognitive dashboard software platform to aid neurosurgical clinical decision-making. Mindtrace Technologies, Inc. will deliver a turn-key software solution that enables neurosurgical teams to map individual patient brain functions, assess and track measures of mental performance throughout care, and integrate with existing medical imaging and data...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Technology Transfer (STTR) Project Grant, awarded to Ai-Neotech LLC in the amount of $275,000 on October 1, 2023, supports the development of a novel consumer product that uses artificial intelligence (AI) and machine learning (ML) models applied to electroencephalogram (EEG) data to predict and mitigate the risk of epileptic seizures for patients and their caregivers. The goal is...
The federal Project Grant award R44AG087855, provided by the National Institute on Aging (CFDA 93.866 Aging Research program), is funding the development of a perivascular space (PVS) mapping toolset as a diagnostic aid for Alzheimer's disease (AD). The $1,193,370 award to Neuroscope Inc., a woman-owned small business located in Scarsdale, NY, aims to commercialize the company's computational techniques for automated, accurate quantification of PVS morphology from MRI scans. The funding will...
This federal Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $994,138 to Modendo Inc., a for-profit small business, to develop and validate a prototype ultrathin endomicroscope instrument for advanced neuroscience research. The project aims to create a high-resolution optical imaging system capable of minimally invasive deep brain exploration using animal models, with potential...
This Small Business Innovation Research (SBIR) Phase II award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Ai Pow LLC, a minority-owned, small disadvantaged business located in College Station, TX. The project aims to develop a hardware-aware AutoML platform to enable efficient deployment of AI models on resource-constrained edge devices for real-time defect detection in...
This $1,011,032 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support Amissa Inc.'s research to develop an innovative approach for early detection of Alzheimer's disease preclinical stages. The key products and services to be delivered under this 1-year award include: Assessing the relationship between health data collected from smartwatches/wearables and cognitive function in a cohort of 50 cognitively normal older adults (aged 65+) with...
This National Science Foundation (NSF) Cooperative Agreement award for $999,988 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development and refinement of a healthcare technology platform that utilizes geometric unified learning. The project aims to enhance the efficiency and accuracy of healthcare diagnostics and monitoring, particularly for diseases that can be diagnosed and monitored using voice and EEG data. The research objectives include...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $303,089 provided funding to Bioimaginix LLC, a small business located in Morgantown, West Virginia, to develop an artificial intelligence (AI)-powered diagnostic tool for early detection of Alzheimer's disease (AD) and mild cognitive impairment (MCI) using magnetic resonance imaging (MRI) scans.

The key products and services delivered under this award include an AI-machine learning algorithm that can accurately classify AD versus MCI patients with 81.41% and 92.75% accuracy, respectively, compared to autopsy-confirmed diagnoses. This platform aims to provide a cost-effective, user-friendly brain imaging analysis tool to assist neurologists and geriatric primary care providers in the early diagnosis of AD, particularly at the MCI stage, to enable timely interventions and care planning. The project has the potential for broader commercial application in diagnosing other neurological conditions such as autism, depression, traumatic brain injuries, and schizophrenia using MRI data.

Generated 4/29/25, 3:33 AM